MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. (“Alto”) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for ...

The Surat Bullet Train station sets a new standard for passenger comfort with thoughtfully designed interiors, natural skylight illumination, and well-ventilated platforms. Spacious lounges, restrooms ...

Since 1946, model railroad enthusiasts have gathered in the basement of the Calumet Park Fieldhouse to work together on the construction of what amounts to a small civilization. The Lake Shore Model ...

Elon Musk's generative artificial intelligence company xAI unveiled its new reasoning model late on Friday, known as Grok 4 Fast. “We used large-scale reinforcement learning to maximize the ...

Aaron Navarro is a CBS News digital reporter covering the 2024 elections. He was previously an associate producer for the CBS News political unit in the 2021 and 2022 election cycles. President Trump ...

President Donald Trump on Friday unveiled a brand-new “gold card” visa scheme, offering a fast track to residency for people willing to pay $1 million. But that wasn’t the only change to immigration ...

The Trump administration and a Republican-led Congress recently zapped federal tax credits meant to encourage large-scale wind, solar and battery storage projects. But a renewable energy advocate says ...

Construction of an addition to the Western Pennsylvania Model Railroad Museum in Richland won’t derail its holiday train show. The 37th annual show is slated to run from Nov. 8 to Jan. 11 at the ...

The Army announced plans Monday to spend $750 million per year on a new initiative to bring Silicon Valley-style entrepreneurial speed to weapons development, particularly drone and anti-drone ...

Senate Republicans are still not done with their effort to alter Senate procedure to expedite the confirmation of blocs of President Trump’s non-cabinet and judicial nominees all at once. But if all ...

Sanofi said its gene therapy to treat neovascular age-related macular degeneration was approved for fast-track development in the U.S. The biopharmaceutical company said Thursday that the Food and ...